Founders Capital Management Pfizer Inc Transaction History

Founders Capital Management

$185 Million
Q4 2025

A detailed history of Founders Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Founders Capital Management holds 12,252 shares of PFE stock, worth $307,280. This represents 0.17% of its overall portfolio holdings.

Number of Shares

12,252

Previous 14,800 17.22%

Holding current value

$307,280

Previous $377,000 18.57%

% of portfolio

0.17%

Previous 0.2%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 15, 2026	SELL	$24.23 - $27.37 $61,738 - $69,738	-2,548 Reduced 17.22%	12,252 $307,000
Q3 2025 Nov 13, 2025	BUY	$23.29 - $25.88 $2,212 - $2,458	95 Added 0.65%	14,800 $377,000
Q2 2025 Jul 18, 2025	SELL	$21.59 - $24.84 $43,352 - $49,878	-2,008 Reduced 12.01%	14,705 $356,000
Q1 2025 Apr 08, 2025	SELL	$25.01 - $27.13 $136,154 - $147,695	-5,444 Reduced 24.57%	16,713 $423,000
Q4 2024 Jan 13, 2025	SELL	$24.8 - $30.19 $78,864 - $96,004	-3,180 Reduced 12.55%	22,157 $587,000

Q3 2024 Oct 07, 2024	BUY	$27.7 - $31.39 $13,296 - $15,067	480 Added 1.93%	25,337 $733,000
Q2 2024 Jul 10, 2024	SELL	$25.26 - $29.6 $55,496 - $65,031	-2,197 Reduced 8.12%	24,857 $695,000
Q1 2024 Apr 10, 2024	SELL	$25.89 - $29.73 $180,686 - $207,485	-6,979 Reduced 20.51%	27,054 $750,000
Q4 2023 Jan 08, 2024	SELL	$26.13 - $33.94 $675,042 - $876,805	-25,834 Reduced 43.15%	34,033 $979,000
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $68,800 - $80,421	-2,144 Reduced 3.46%	59,867 $1.99 Million
Q2 2023 Jul 07, 2023	SELL	$36.12 - $41.79 $29,184 - $33,766	-808 Reduced 1.29%	62,011 $2.27 Million
Q1 2023 Apr 12, 2023	BUY	$39.39 - $51.28 $21,664 - $28,204	550 Added 0.88%	62,819 $2.56 Million
Q4 2022 Jan 09, 2023	BUY	$41.75 - $54.5 $1,503 - $1,962	36 Added 0.06%	62,269 $3.19 Million
Q3 2022 Oct 06, 2022	SELL	$43.76 - $53.42 $34,307 - $41,881	-784 Reduced 1.24%	62,233 $2.72 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $230,137 - $272,870	-4,946 Reduced 7.28%	63,017 $3.3 Million
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $10,288 - $15,251	-249 Reduced 0.37%	67,963 $4.01 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $991,101 - $1.27 Million	-25,251 Reduced 27.02%	68,212 $2.93 Million
Q2 2021 Jul 15, 2021	SELL	$35.91 - $40.68 $25,208 - $28,557	-702 Reduced 0.75%	93,463 $3.66 Million
Q1 2021 Jun 07, 2021	SELL	$33.49 - $37.77 $178,367 - $201,163	-5,326 Reduced 5.35%	94,165 $6,000
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $278,135 - $353,673	-8,310 Reduced 7.71%	99,491 $3.66 Million
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $184,371 - $263,427	-6,821 Reduced 5.95%	107,801 $3.52 Million
Q4 2019 Jan 24, 2020	BUY	$32.92 - $37.36 $292,428 - $331,868	8,883 Added 8.4%	114,622 $4.49 Million
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $825,343 - $1.07 Million	25,403 Added 31.62%	105,739 $3.8 Million
Q2 2019 Jul 11, 2019	SELL	$36.98 - $41.52 $10,576 - $11,874	-286 Reduced 0.35%	80,336 $3.48 Million
Q1 2019 Apr 17, 2019	SELL	$37.5 - $41.2 $7,875 - $8,652	-210 Reduced 0.26%	80,622 $3.42 Million
Q4 2018 Jan 14, 2019	BUY	$38.47 - $43.86 $14,618 - $16,666	380 Added 0.47%	80,832 $3.53 Million
Q3 2018 Oct 05, 2018	BUY	$34.47 - $41.81 $772,541 - $937,045	22,412 Added 38.61%	80,452 $3.55 Million
Q2 2018 Jul 09, 2018	BUY	$32.98 - $35.16 $112,428 - $119,860	3,409 Added 6.24%	58,040 $2.11 Million
Q1 2018 Apr 09, 2018	BUY	$31.91 - $37.02 $19,465 - $22,582	610 Added 1.13%	54,631 $1.94 Million
Q4 2017 Jan 22, 2018	BUY	$33.26 - $35.29 $20,953 - $22,232	630 Added 1.18%	54,021 $1.96 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $1.66 Million - $1.82 Million	53,391	53,391 $1.91 Million

Others Institutions Holding PFE

# of Institutions

3,372

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Founders Capital Management with notifications on news.

Account

Founders Capital Management Pfizer Inc Transaction History